USPTO 2015–2025 USPTO PatentsView US Corporation

Stemnion, Inc.

USPTO PatentsView assignee record - 14 granted patents across 5 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Stemnion ranks #20,461 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 5 technology areas.

#20,461
of 49,997 US assignees by volume
9th percentile
by Innovation Score (21.8/100)
7.6
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20461 · US Corporation #20,461 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 14 grants
  • MID-PACK #20,461/49,997
  • PHOTO-FINISH Star Ally Internatio…
  • CPC-NARROW A61K · 5 areas
  • INNOV-THIN 21.8/100
  • CLAIMS-SPARSE 7.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Star Ally International Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stemnion’s 21.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Stemnion

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Stemnion's Innovation Score is 21.8/100 (9th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Stemnion?

Each dot is one of Stemnion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stemnion’s own 7.6 claims/patent is at or below the 19.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Stemnion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 13.913.91414.1 510152025 Granted patents (volume) Avg claims / patent Star Ally International Limited - 14, 19.36Star Ally Interna…Starlogik IP LLC - 14, 19.07Starlogik IPState Street Corporation - 14, 21State StreetSteiner AG Weggis - 14, 16.14Steiner WeggisSteris Instrument Management Services, Inc. - 14, 17.43Steris Instrument…Stimscience Inc. - 14, 20.43StimscienceStrix Limited - 14, 16.64StrixSunfolding, Inc. - 14, 19.43SunfoldingStemnion, Inc. - 14, 7.57Stemnion
Stemnion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stemnion's grants concentrate

Stemnion, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 85.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (7 grants) versus a trough of 3 in 2016. By volume, Stemnion sits between Star Ally International Limited and Sunfolding, Inc..

Who files at Stemnion's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Stemnion holds 14 patents at rank #20,403, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Stemnion

By rank, the assignees closest to #20,403 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Stemnion's primary technology class.

Stemnion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

22 9th percentile higher than 9% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2345678 201520162017 4
USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Stemnion, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 7 50.0%
2016 3 21.4%
2017 4 28.6%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Stemnion, Inc.'s patent record in context - here's where to go next.

  • Stemnion, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 85.7% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #20,461 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Stemnion, Inc. against Star Ally International Limited, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 21.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.